| An increased fraction of circulating miR-363 and miR-16 is particle bound in patients with chronic lymphocytic leukaemia as compared to normal subjects. |
Alharthi A, Beck D, Howard DR, Hillmen P, Oates M, Pettitt A, Wagner SD. |
2018 |
BMC Res Notes |
Link
|
| Telomere length predicts for outcome to FCR chemotherapy in CLL. |
Norris K, Hillmen P, Rawstron A, Hills R, Baird DM, Fegan CD, Pepper C. |
2019 |
Leukemia |
Link
|
| Combined analysis of IGHV mutations, telomere length and CD49d identifies long-term progression-free survivors in TP53 wild-type CLL treated with FCR-based therapies. |
Pepper AGS, Zucchetto A, Norris K, Tissino E, Polesel J, Soe Z, Allsup D, Hockaday A, Ow PL, Hillmen P, Rawstron A, Catovsky D, Bulian P, Bomben R, Baird DM, Fegan CD, Gattei V, Pepper C. |
2022 |
Leukemia |
Link
|